Announced Tue, 23 Jun · 16:04 IST
Trading window closure for Q1 FY27 results
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.2%1-day move
₹122.00
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-1.2-3.5-1.1+1.2-0.8+2.8-1.6-2.5——
Up moveDown movePending
AI summary
Godavari Drugs has informed BSE that the trading window for its securities will remain closed for all designated persons and their immediate relatives from July 1, 2026 until 48 hours after the declaration of unaudited financial results for Q1 FY27 (quarter ending June 30, 2026). This is a routine compliance measure under SEBI Insider Trading Regulations.
Likely market impact
Routine compliance filing. Designated persons cannot trade in the stock until 48 hours after Q1 FY27 results are announced.